Alexion Pharma recalls certain lots of intravenous drug SolirisReuters(Reuters) – Alexion Pharmaceuticals Inc said it is voluntarily recalling certain lots of Soliris, an intravenous drug for two potentially fatal blood disorders that can damage the kidneys, heart and brain. The company said the recall was related to its earlier …New Data Presented at the ERA-EDTA Congress Demonstrate Efficacy of Soliris …Wall Street JournalAlexion Initiates Voluntary Nationwide Recall of Certain Lots of Soliris …MarketWatchAlexion Initiates Voluntary Recall Of Certain Lots Of Soliris – Quick FactsNASDAQall 5 news articles …Read Full Story
Alexion Pharma recalls certain lots of intravenous drug Soliris - Reuters
Real Estate of Cebu
